Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter study
Authors:
- 1 November 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (15) , J35-J43
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profilesAtherosclerosis, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Lipid-Lowering DrugsDrugs, 1987
- Immunoturbidimetric determination of apolipoproteins A-1 and B in serumScandinavian Journal of Clinical and Laboratory Investigation, 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Clinical results with gemfibrozil and background to the Helsinki Heart StudyThe American Journal of Cardiology, 1983
- Summary estimates of cholesterol used to predict coronary heart disease.Circulation, 1983
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up studyActa Medica Scandinavica, 1982
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJournal of Clinical Investigation, 1955